LivaNova (LIVN) Other financing activities (2015 - 2026)
LivaNova (LIVN) reported Other financing activities of $1.7 million for Q1 2026, up 3780.43% on a YoY basis from $43629.1 in Q1 2025, and down 28.6% sequentially from $2.4 million in Q4 2025.
LivaNova (LIVN) Other financing activities (2015 - 2026) Analysis & Trends
LivaNova (LIVN) has 12 years of Other financing activities data on file, last reported at $1.7 million in Q1 2026.
- For the quarter ending Q1 2026, Other financing activities rose 3780.43% year-over-year to $1.7 million; the trailing twelve-month figure through Mar 2026 stood at $1.7 million (up 110.72% YoY), and the FY2024 full-year result was $6.3 million, changed N/A from the prior year.
- Other financing activities fell to $1.7 million in Q1 2026, from $2.4 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $22.5 million in Q1 2024 to a low of -$17.5 million in Q3 2024.
- A 5-year average of $619928.6 and a median of $40500.0 in 2022 frame the typical range for Other financing activities.
- Across the five-year window, Other financing activities sank 1329.44% in 2024 and jumped 3780.43% in 2026, its largest moves.
- Tracing LIVN's Other financing activities over 5 years: stood at -$1.1 million in 2022, then retreated by 25.98% to -$1.4 million in 2023, then soared by 191.18% to $1.3 million in 2024, then soared by 80.58% to $2.4 million in 2025, then dropped by 28.6% to $1.7 million in 2026.
- Business Quant data shows LIVN's Other financing activities at $1.7 million in Q1 2026, $2.4 million in Q4 2025, and -$2.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | LivaNova | 4.30 Bn | 3.76 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.69 Mn |
| Mar 31, 2026 | 1.69 Mn |
| Dec 31, 2025 | 2.37 Mn |
| Dec 31, 2025 | 2.37 Mn |
| Sep 30, 2025 | -2.37 Mn |
| Sep 30, 2025 | -2.37 Mn |
| Jun 30, 2025 | 46,000.00 |
| Jun 30, 2025 | 46,000.00 |
| Mar 31, 2025 | -46,000.00 |
| Mar 31, 2025 | -46,000.00 |
| Dec 31, 2024 | 1.31 Mn |
| Dec 31, 2024 | 1.31 Mn |
| Sep 30, 2024 | -17.50 Mn |
| Sep 30, 2024 | -17.50 Mn |
| Mar 31, 2024 | 22.52 Mn |
| Mar 31, 2024 | 22.52 Mn |
| Dec 31, 2023 | -1.44 Mn |
| Dec 31, 2023 | -1.44 Mn |
| Sep 30, 2023 | 1.42 Mn |
| Sep 30, 2023 | 1.42 Mn |